Aetion, which provides real-world evidence and analytics to drug companies, payers, life sciences companies, and regulatory bodies, announced its acquisition of artificial-intelligence-powered Replica Analytics for an undisclosed sum. Replica uses AI to generate synthetic health data based on real-world data. The synthetic data maintain the statistical properties of the original data while ensuring complete privacy protection, which will open a wealth of health information for researchers, according to the company.
Read More
Read More